Lilly reveals phase III trial data on back pain
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Aug, 2012
Singapore: Eli Lilly and Company published data from a phase III trial comparing the effects of FORTEO (teriparatide, rD...Read more
Takeda's diabetes drug gets Chinese FDA nod
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: Japanese major Takeda Pharmaceutical has said that the China's State Food and Drug Administration (SFDA) has ...Read more
Aveo, Astellas report cancer trial results
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2013
Singapore: Aveo Oncology and Astellas Pharma announced overall survival (OS) for tivozanib, an investigational agent, fr...Read more
UK, Belgium nod for Bone Therapeutics' therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2013
Singapore: Europe-based Bone Therapeutics, a biopharmaceutical company focused on innovative cell therapy products for t...Read more
Japan, Singapore to bring innovation in drug, device, technology
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2013
Singapore: Japan's Kanagawa Prefecture's Global Collaboration Center for Life Innovation (GCC) and the Agency for Scienc...Read more
Cancer claimed 8.2 mn lives in 2012: UN
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2014
Singapore: Cancer is the biggest cause of mortality worldwide as the killer disease claimed an estimated 8.2 million liv...Read more
Protagonist, Ironwood expand peptide R&D deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Dec, 2012
Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collab...Read more
UK recommends BMS's Yervoy for skin cancer
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2012
Singapore: National Institute of Health and Clinical Excellence (NICE) has decided to recommend Bristol-Myers Squibb's Y...Read more
Singapore opens research centre for circulating tumour cell
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Departme...Read more
TauRx gets $10.5 mn funding from Dundee Corp
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013
Singapore: Singapore-based TauRx Pharmaceuticals recieved equity investment of $10.5 million from Toronto's Dundee Corpo...Read more
FDA: AbbVie Hepatitis therapy is a 'breakthrough'
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 May, 2013
Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatme...Read more
NIH to develop therapeutics for nicotine addiction
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: The National Institutes of Health (NIH), US, has launched three projects that will focus on development of t...Read more
NZ firm to raise funds for Australia trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 t...Read more
TSRI, Takeda expand research collaboration
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2013
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collabo...Read more
Prima recruits patients for cancer vaccine trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Mar, 2013
Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. P...Read more
Merck pays Bionomics $172mn for pain molecules
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and...Read more
Bayer initiates trial of new rFVIII to treat hemophilia A
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2012
Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that i...Read more
Eli Lilly, China firm to co-develop diabetes drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Jul, 2014
‎Singapore: China based pharmaceutical company, Yabao Pharmaceutical, has partnered with Eli Lilly to co-develop L...Read more